Delivery Order SPE2DB20D3101-SPE2DB21FH4P2
- Not listed
- This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is for the provision of a prime vendor pharmaceutical branch in Philadelphia for the Defense Logistics Agency (DLA). The $11,636.45 delivery order contract has a firm fixed price and runs through November 2020. Amerisourcebergen, a subsidiary of the parent company Cencora, Inc., holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical to supply a...
- This federal contract award is for a Prime Vendor Pharmacy Branch in Philadelphia, awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distribution company and subsidiary of Cencora, Inc. The contract, valued at $7,338.23, is a Firm Fixed Price Delivery Order awarded by the Defense Logistics Agency (DLA) to support military treatment facilities, veterans' healthcare programs, and other federal medical institutions. The contract covers a wide range of pharmaceutical products and...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, to provide a Prime Vendor Pharmaceutical Branch in Philadelphia. The contract, valued at $1,179.11, is a firm fixed-price delivery order that runs through December 30, 2020. Amerisourcebergen is a subsidiary of the parent company Cencora, Inc., which holds a significant $999,999,999 Indefinite Delivery Contract with the DLA Troop Support Medical to...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for a Prime Vendor Pharmacy Branch in Philadelphia. The $10,366.35 firm fixed-price delivery order covers a range of pharmaceutical products and medical supplies, including specialty medications, brand-name and generic drugs, vaccines, syringes, vials, and test kits across various therapeutic areas. Amerisourcebergen holds a significant $999,999,999...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distribution company. The $8,642.21 firm fixed-price delivery order is for a Prime Vendor Pharmaceutical Branch in Philadelphia, with a completion date of September 16, 2020. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical for...
- This federal contract award is for a Prime Vendor Pharmaceutical Branch-Philadelphia delivery order valued at $4,632.00, awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a performance period through May 20, 2021 and is a firm fixed price delivery order. Amerisourcebergen, through its parent company Cencora, Inc., holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with the...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,712.34 firm fixed-price delivery order is for a Prime Vendor Pharmacy Branch in Philadelphia, with a completion date of June 19, 2020. Amerisourcebergen, a subsidiary of the parent company Cencora, Inc., has a significant Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 with the DLA Troop...
- The U.S. Defense Logistics Agency (DLA) awarded a $45,349.55 Firm Fixed Price delivery order contract to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, to provide a Prime Vendor Pharmacy Branch in Philadelphia. The contract has no set-aside designation and runs through February 2021. Amerisourcebergen is a subsidiary of the parent company Cencora, Inc., which holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical to deliver a comprehensive...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $7,895.25, is a Delivery Order under the Prime Vendor Pharmaceutical Branch-Philadelphia program. It covers the delivery of a range of pharmaceutical products and medical supplies, including specialty medications, brand-name and generic drugs, vaccines, syringes, vials, and other critical medical...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for a Prime Vendor Pharmacy Branch in Philadelphia. The $47,175.89 delivery order falls under a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical valued at up to $999,999,999.00, which runs through November 2026. This IDC enables Amerisourcebergen to efficiently provide a comprehensive range of pharmaceutical products and...
- SPE2DB20D3101Indefinite Delivery Contract
- SPE2DB20D3101-SPE2DB21FH4P2Delivery Order
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the provision of a Prime Vendor Pharmaceutical Branch in Philadelphia. The contract, valued at $7,902.86, is a Firm Fixed Price Delivery Order that does not have a set-aside designation, indicating open competition. Amerisourcebergen is a subsidiary of the parent company Cencora, Inc., which holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, serving as a primary vehicle for delivering a comprehensive range of pharmaceutical products and medical supplies to support military and veteran healthcare programs globally. This contract award demonstrates Amerisourcebergen's role as a critical supplier of essential medical commodities, including specialty medications, brand-name and generic drugs, vaccines, syringes, vials, and test kits, to federal government agencies.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $7.9k | 1/5/21 |